{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T20:30:07Z","timestamp":1784752207823,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.arbres.2014.06.018","type":"journal-article","created":{"date-parts":[[2014,10,9]],"date-time":"2014-10-09T01:21:21Z","timestamp":1412817681000},"page":"440-448","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Niveles de prop\u00e9ptido aminoterminal de procol\u00e1geno tipos i y iii y gravedad de la enfermedad pulmonar intersticial en mujeres mexicanas con esclerosis sist\u00e9mica progresiva"],"prefix":"10.1016","volume":"51","author":[{"given":"Laura","family":"Gonzalez-Lopez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto D.","family":"Rocha-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva M.","family":"Olivas-Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Araceli","family":"Garcia-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana R.","family":"Peguero-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Flores-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto I.","family":"Villa-Manzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraya A.","family":"Zavaleta-Mu\u00f1iz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Salazar-Paramo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayra","family":"Mej\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Ju\u00e1rez-Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Vazquez-del Mercado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto G.","family":"Cardona-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Trujillo-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnulfo H.","family":"Nava-Zavala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge I.","family":"Gamez-Nava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arbres.2014.06.018_bib0005","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2340\/00015555568392","article-title":"Pathogenesis and staging of scleroderma","volume":"56","author":"Winkelmann","year":"1976","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.arbres.2014.06.018_bib0010","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0889-857X(03)00025-5","article-title":"Interstitial lung disease in scleroderma","volume":"29","author":"White","year":"2003","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.arbres.2014.06.018_bib0015","doi-asserted-by":"crossref","first-page":"136","DOI":"10.7326\/0003-4819-134-2-200101160-00015","article-title":"American Thoracic Society; European Respiratory Society; American College of Chest Physicians. Idiopathic pulmonary fibrosis: Prevailing and evolving hypotheses about its pathogenesis and implications for therapy","volume":"134","author":"Selman","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.arbres.2014.06.018_bib0020","doi-asserted-by":"crossref","first-page":"v62","DOI":"10.1093\/rheumatology\/ken272","article-title":"Histopathology and bronchoalveolar lavage","volume":"47","author":"Silver","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.arbres.2014.06.018_bib0025","first-page":"165","article-title":"Increased levels of amino terminal propeptide of type iii procollagen are an unfavourable predictor of survival in systemic sclerosis","volume":"23","author":"Nagy","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.arbres.2014.06.018_bib0030","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jbspin.2006.01.022","article-title":"Prognostic markers for systemic sclerosis","volume":"73","author":"Meyer","year":"2006","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.arbres.2014.06.018_bib0035","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/0190-9622(95)90341-0","article-title":"The use of serologic markers for collagen synthesis and degradation in systemic sclerosis","volume":"32","author":"Heickendorff","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.arbres.2014.06.018_bib0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/03009749209095054","article-title":"Serum levels of aminoterminal type iii procollagen peptide and hyaluronan predict mortality in systemic sclerosis","volume":"21","author":"Scheja","year":"1992","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.arbres.2014.06.018_bib0045","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/rheumatology\/39.10.1110","article-title":"Circulating collagen metabolites in systemic sclerosis. Differences between limited and diffuse form and relationship with pulmonary involvement","volume":"39","author":"Scheja","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.arbres.2014.06.018_bib0050","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1046\/j.1365-2133.1998.02558.x","article-title":"Circulating type i collagen degradation products: A new serum marker for clinical severity in patients with scleroderma?","volume":"139","author":"Hunzelmann","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.arbres.2014.06.018_bib0055","first-page":"356","article-title":"Serological assessment of type i collagen burden in scleroderma spectrum disorders: A systematic review","volume":"22","author":"Dziadzio","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.arbres.2014.06.018_bib0060","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","volume":"23","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arbres.2014.06.018_bib0065","first-page":"202","article-title":"Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/j.arbres.2014.06.018_bib0070","first-page":"1281","article-title":"Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis","volume":"22","author":"Clements","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.arbres.2014.06.018_bib0075","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/art.1790080312","article-title":"Concurrent validity of the Health Assessment Questionnaire Disability Index in Scleroderma","volume":"8","author":"Poole","year":"1995","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.arbres.2014.06.018_bib0080","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/rheumatology\/36.2.239","article-title":"Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis","volume":"36","author":"Denton","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.arbres.2014.06.018_bib0085","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/rheumatology\/kel221","article-title":"Validity of the Saint George's Respiratory Questionnaire in the evaluation of the health-related quality of life in patients with interstitial lung disease secondary to systemic sclerosis","volume":"46","author":"Beretta","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.arbres.2014.06.018_bib0090","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories ATS statement: Guidelines for the six-minute walk test","volume":"166","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2014.06.018_bib0095","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"ATS\/ERS Task Force Standarisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2014.06.018_bib0100","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2214\/ajr.169.4.9308447","article-title":"Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: Correlation with pathologic scoring","volume":"169","author":"Kazerooni","year":"1997","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.arbres.2014.06.018_bib0105","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/clinchem\/42.6.947","article-title":"Immunoassay for intact amino-terminal propeptide of human type i procollagen","volume":"42","author":"Melkko","year":"1996","journal-title":"Clin Chem"},{"key":"10.1016\/j.arbres.2014.06.018_bib0110","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/clinchem\/34.4.715","article-title":"Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type iii procollagen","volume":"34","author":"Risteli","year":"1988","journal-title":"Clin Chem"},{"key":"10.1016\/j.arbres.2014.06.018_bib0115","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1183\/09031936.95.08091559","article-title":"Predictive value of serum iii procollagen for diagnosis of pulmonary involvement in patients with scleroderma","volume":"8","author":"Diot","year":"1995","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2014.06.018_bib0120","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1164\/ajrccm.159.3.9805060","article-title":"Type iii and type i procollagen markers in fibrosing alveolitis","volume":"159","author":"Lammi","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2014.06.018_bib0125","first-page":"69","article-title":"Type iii procollagen N-terminal propeptide, soluble interleukin-2 receptor, and von Willebrand factor in systemic sclerosis","volume":"19","author":"Lee","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.arbres.2014.06.018_bib0130","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3343\/alm.2012.32.2.105","article-title":"Current recommendations for laboratory testing and use of bone turnover markers in management of osteoporosis","volume":"32","author":"Lee","year":"2012","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.arbres.2014.06.018_bib0135","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1007\/s00198-014-2646-0","article-title":"PINP as a biological response marker during teriparatide treatment for osteoporosis","volume":"25","author":"Krege","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.arbres.2014.06.018_bib0140","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1186\/ar2366","article-title":"Role of resistin as a marker of inflammation in systemic lupus erythematosus","volume":"10","author":"Almehed","year":"2008","journal-title":"Arthritis Res Ther"},{"issue":"Pt 5","key":"10.1016\/j.arbres.2014.06.018_bib0145","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1258\/acb.2011.011040","article-title":"Comparison of total and intact aminoterminal propeptide of type i procollagen assays in patients with breast cancer with or without bone metastases","volume":"48","author":"Marin","year":"2011","journal-title":"Ann Clin Biochem"},{"issue":"Pt 1","key":"10.1016\/j.arbres.2014.06.018_bib0155","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1258\/acb.2009.009110","article-title":"Difference between total and intact assays for N-terminal propeptide of type i procollagen reflects degradation of pN-collagen rather than denaturation of intact propeptide","volume":"47","author":"Koivula","year":"2010","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.arbres.2014.06.018_bib0160","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/aas.12182","article-title":"Finnali Study Group. Serum markers of collagen synthesis and degradation in acute respiratory failure patients","volume":"57","author":"Okkonen","year":"2013","journal-title":"Acta Anaesthesiol Scand"}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289614003196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289614003196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T04:31:42Z","timestamp":1689568302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289614003196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0300289614003196"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2014.06.018","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Niveles de prop\u00e9ptido aminoterminal de procol\u00e1geno tipos i y iii y gravedad de la enfermedad pulmonar intersticial en mujeres mexicanas con esclerosis sist\u00e9mica progresiva","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2014.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 SEPAR. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}